National Health Investors (NYSE:NHI – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. They presently have a $94.00 price target on the real estate investment trust’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 14.36% from the company’s previous close.
Several other brokerages have also recently issued reports on NHI. Truist Financial dropped their target price on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a report on Wednesday. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a report on Tuesday, January 20th. National Bank Financial set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th. Wells Fargo & Company increased their price objective on shares of National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research report on Friday, March 27th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $87.83.
Get Our Latest Stock Analysis on NHI
National Health Investors Stock Performance
National Health Investors (NYSE:NHI – Get Free Report) last announced its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.01). The firm had revenue of $105.82 million during the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, sell-side analysts anticipate that National Health Investors will post 5.05 earnings per share for the current year.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Renaissance Group LLC lifted its stake in shares of National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock valued at $245,000 after purchasing an additional 117 shares during the period. GAMMA Investing LLC increased its holdings in National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 136 shares in the last quarter. Captrust Financial Advisors raised its position in shares of National Health Investors by 1.7% in the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after acquiring an additional 146 shares during the period. PNC Financial Services Group Inc. raised its position in shares of National Health Investors by 5.0% in the third quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the real estate investment trust’s stock worth $297,000 after acquiring an additional 177 shares during the period. Finally, Arizona State Retirement System boosted its stake in shares of National Health Investors by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 13,818 shares of the real estate investment trust’s stock worth $1,099,000 after acquiring an additional 191 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.
National Health Investors Company Profile
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Stories
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
